Active, not recruiting
Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
NCT04732871
- Conditions
- Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
- Locations
-
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site San Diego, California, United States